LNP Technology Platform

Preparation

Instrument-free Preparation

Classical LNP manufacturing relies on microfluidic mixing devices or T-junction systems to achieve controlled LNP assembly at defined flow rates. While these approaches deliver highly reproducible particles, they require specialised equipment that is often unavailable in standard biology laboratories. For early-stage research — initial in vitro screening in cell culture and exploratory in vivo studies in mice — a pipette-based, vortex-assisted protocol provides a rapid, accessible, and surprisingly robust alternative that requires no capital equipment beyond a standard laboratory vortex mixer.

The method exploits the same self-assembly thermodynamics as microfluidic approaches. When an ethanol solution of the four lipid components is rapidly diluted into aqueous buffer containing RNA, the hydrophobic collapse of the ionizable lipids drives simultaneous electrostatic condensation of the RNA and formation of a lipid-enclosed nanoparticle. Controlled by hand mixing or a vortex mixer at a fixed speed, particles in the 80–180 nm range can be routinely obtained, fully suitable for transfection of cultured cells and for intravenous or intramuscular injection in mouse models.

Instrument-free LNP preparation: Step 1 mix lipids+RNA, Step 2 vortex 10s, Step 3 add to cells
Step 1 – Step 3 in less than 5 minutes
Instrument-free LNP preparation: analyse after 24h
Analyse after 24h
1
Prepare

Organic phase: Dissolve the four lipid components — ionizable lipid, structural lipid, cholesterol, and PEG-lipid — at the desired molar ratio in 99% ethanol (10–25 mM total lipid concentration).

Aqueous phase: Dilute RNA in 25 mM HEPES buffer pH 7.0 (EUFECT® formulations do not require an acidic buffer.)

2
Mix · 10 s

Add the lipid/ethanol phase dropwise into the RNA/buffer phase at a 1 : 5 volume ratio, while vortexing at 2,500–3,000 rpm for 5 seconds.

For in vivo application dialyse against PBS to remove ethanol.

3
Use

In vitro: Add LNPs directly to the culture medium to achieve a final particle concentration of approximately 3 × 10⁹ particles/mL. Incubate the cells for 24 hours at 37 °C.

In vivo: Filter through 0.22 µm, then administer by IV tail-vein or IM injection.

< 5 min
Total hands-on time
80–180 nm
Target particle size
50 µL – 1 mL
Batch scale
No equipment
Beyond vortex mixer